Overview

Pediatric Interventional Cardiology Market is forecasted to value over USD 1.9 billion by 2027 end and register a CAGR of 8.8% from the forecast period 2020-2027.

FutureWise Market Research has illustrated a report on the market. The report provides an in-depth anatomy of Pediatric Interventional Cardiologymarket trends affecting its growth. Moreover, it includes intricate insights on profitability graph, Pediatric Interventional Cardiologymarket share, SWOT analysis and geographical augmentation of this business. Furthermore, the report provides information on the status of key market players in the competitive landscape analysis of the market.
The Pediatric Interventional Cardiology market is projected to achieve significant growth by the end of the forecast period as per the research study conducted by FutureWise research analysts. The report explains that this business is predicted to record a remarkable growth rate over the forecast period. This report provides important information regarding the total valuation that this industry holds presently and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Pediatric Interventional Cardiology market are:

• Medtronic 
• St Jude Medical 
• Gore Medical 
• Johnson and Johnson 
• Boston Scientific 
• Edward LifeSciences 
• Abbott Vascular 
• GE Healthcare 
• Siemens Healthcare 
• Biotronic 

(Note: The list of the major players will be updated with the latest market scenario and trends)

Pediatric Interventional Cardiology Market Segmentation:

By Device Type

• Congenital Heart Defect Closure Devices
• Atrial Septal Defect (ASD), Ventricular Septal Defect (VSD), and Patent Foramen Ovale (PFO) Closure Devices
• Patent Ductus Arteriosus (PDA) Closure Devices
• Left Atrial Appendage (LAA) Closure Devices
• Transcatheter Heart Valves
• Transcatheter Pulmonary Valves
• Transcatheter Aortic Valves

By Region

• North America
• Europe
• Asia-Pacific
• Rest of the world

Competitive Landscape:

• Tier 1 players- established companies in the market with a major market share  
• Tier 2 players 
• Emerging players which are growing rapidly 
• New Entrants

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the Pediatric Interventional Cardiology market by device type and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions — North America, Europe, Asia Pacific and rest of the world
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization services offered are free of charge with purchase of any license of the report.
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
         1.1. Objectives of the Study 
         1.2. Market Definition 
         1.3. Market Scope 
                 1.3.1. Years Considered for the Study
                 1.3.2. Market Covered
         1.4. Currency 
         1.5. Limitations 
         1.6. Stakeholders 
 2.  Research Methodology 
         2.1. Research Data 
                2.1.1. Secondary Data
                           2.1.1.1. Key Data from Secondary Sources
                2.1.2. Primary Data
                           2.1.2.1. Key Data from Primary Sources
         2.2. Market Size Estimation 
         2.3. Market Breakdown and Data Triangulation 
         2.4. Assumptions for the Study  
3. Executive Summary
         3.1 Market Outlook
         3.2 Segment Outlook
         3.3 Competitive Insights
4. Global Pediatric Interventional Cardiology Market Variables, Trends & Scope
         4.1. Market Lineage Outlook
         4.2. Penetration and Growth Prospect Mapping
         4.3. Industry Value Chain Analysis
         4.4. Cost Analysis Breakdown
         4.5. Technology Overview
         4.6. Regulatory Framework
                 4.6.1. Reimbursement Framework
                 4.6.2. Standards And Compliances
5. Global Pediatric Interventional Cardiology Market Overview
         5.1. Market Dynamics
                 5.1.1. Market Driver Analysis
                            5.1.1.1. Increasing focus of Pediatric Interventional Cardiology Companies on Brand Protection
                            5.1.1.2. Untapped Opportunities in Emerging Regions
                 5.1.2. Market Restraint Analysis
                            5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
                 5.1.3. Industry Challenges
                            5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Pediatric Interventional Cardiology Market Analysis Tools
         6.1. Industry Analysis - Porter’s
                 6.1.1. Supplier Power
                 6.1.2. Buyer Power
                 6.1.3. Substitution Threat
                 6.1.4. Threat from New Entrants
                 6.1.5. Competitive Rivalry
         6.2. Pestel Analysis
                 6.2.1. Political Landscape
                 6.2.2. Environmental Landscape
                 6.2.3. Social Landscape
                 6.2.4. Technology Landscape
                 6.2.5. Legal Landscape
         6.3. Major Deals And Strategic Alliances Analysis
                 6.3.1. Joint Ventures
                 6.3.2. Mergers and Acquisitions
                 6.3.3. Licensing and Partnership
                 6.3.4. Technology Collaborations
                 6.3.5. Strategic Divestments
         6.4. Market Entry Strategies
         6.5. Case Studies
7. Global Pediatric Interventional Cardiology Market, By Device Type Historical Analysis and Forecast 2020-2027 (USD Million)
         7.1. Congenital Heart Defect Closure Devices
                 7.1.1. Atrial Septal Defect (ASD), Ventricular Septal Defect (VSD), and Patent Foramen Ovale (PFO) Closure Devices
                 7.1.2. Patent Ductus Arteriosus (PDA) Closure Devices
                 7.1.3. Left Atrial Appendage (LAA) Closure Devices
         7.2. Transcatheter Heart Valves
                 7.2.1. Transcatheter Pulmonary Valves
                 7.2.2. Transcatheter Aortic Valves
8. North America Pediatric Interventional Cardiology Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million)
         8.1. Introduction
         8.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019
                 8.2.1. U.S.A
                 8.2.2. Canada
                 8.2.3. Mexico
         8.3. Market Size (USD Million) Forecast for North America 2020-2027 
9. Latin America Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million)
         9.1. Introduction
         9.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019
                 9.2.1. Brazil
                 9.2.2. Venezuela
                 9.2.3. Argentina
                 9.2.4. Rest of Latin America
         9.3. Market Size (USD Million) Forecast for Latin America 2020-2027  
10. Europe Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million)
         10.1. Introduction
         10.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019
                   10.2.1. Germany
                   10.2.2. U.K
                   10.2.3. France
                   10.2.4. Italy
                   10.2.5. Spain
                   10.2.6. Russia
                   10.2.7. Poland
                   10.2.8. Rest of Europe
         10.3. Market Size (USD Million) Forecast for Europe 2020-2027
11. Asia Pacific Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million)
         11.1. Introduction
         11.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019
                   11.2.1. Japan
                   11.2.2. China
                   11.2.3. India
                   11.2.4. Australia and New Zealand
                   11.2.5. ASEAN
                   11.2.6. Rest of Asia Pacific
         11.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
12. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
         12.1. Introduction
         12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
                   12.2.1. Saudi Arabia
                   12.2.2. UAE
                   12.2.3. South Africa
                   12.2.4. Egypt
         12.3. Market Size (USD Million) Forecast for MEA 2020-2027
13. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)
           13.1. Medtronic
                     13.1.1. Company Overview
                     13.1.2. Product Portfolio
                     13.1.3. SWOT Analysis
                     13.1.4. Financial Overview
                     13.1.5. Strategic Overview
           13.2. St Jude Medical
                     13.2.1. Company Overview
                     13.2.2. Product Portfolio
                     13.2.3. SWOT Analysis
                     13.2.4. Financial Overview
                     13.2.5. Strategic Overview
           13.3. Gore Medical
                     13.3.1. Company Overview
                     13.3.2. Product Portfolio
                     13.3.3. SWOT Analysis
                     13.3.4. Financial Overview
                     13.3.5. Strategic Overview
           13.4. Johnson and Johnson
                     13.4.1. Company Overview
                     13.4.2. Product Portfolio
                     13.4.3. SWOT Analysis
                     13.4.4. Financial Overview
                     13.4.5. Strategic Overview
           13.5 Boston Scientific
                     13.5.1. Company Overview
                     13.5.2. Product Portfolio
                     13.5.3. SWOT Analysis
                     13.5.4. Financial Overview
                     13.5.5. Strategic Overview
           13.6 Edward LifeSciences
                     13.6.1. Company Overview
                     13.6.2. Product Portfolio
                     13.6.3. SWOT Analysis
                     13.6.4. Financial Overview
                     13.6.5. Strategic Overview
           13.7. Abbott Vascular
                     13.7.1. Company Overview
                     13.7.2. Product Portfolio
                     13.7.3. SWOT Analysis
                     13.7.4. Financial Overview
                     13.7.5. Strategic Overview
           13.8. GE Healthcare
                     13.8.1. Company Overview
                     13.8.2. Product Portfolio
                     13.8.3. SWOT Analysis
                     13.8.4. Financial Overview
                     13.8.5. Strategic Overview
           13.9. Siemens Healthcare
                     13.9.1. Company Overview
                     13.9.2. Product Portfolio
                     13.9.3. SWOT Analysis
                     13.9.4. Financial Overview
                     13.9.5. Strategic Overview
           13.10. Biotronic
                     13.10.1. Company Overview
                     13.10.2. Product Portfolio
                     13.10.3. SWOT Analysis
                     13.10.4. Financial Overview
                     13.10.5. Strategic Overview
14. FutureWise SME Key Takeaway Points for Client

Tables

Figures